10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors

Key Takeaways

  • Michaelis-Menten kinetics describe enzyme reaction rates via Vmax and Km, while Lineweaver-Burk double reciprocal plots allow clear graphical determination of inhibition types.
  • Competitive inhibitors bind the active site (increasing Km without altering Vmax), non-competitive inhibitors bind allosteric sites (decreasing Vmax with Km unchanged), and uncompetitive inhibitors bind the ES complex (decreasing both Km and Vmax).
  • Water-soluble vitamins serve as essential metabolic coenzymes: Thiamine (B1) for oxidative decarboxylation, Niacin (B3) for NAD+/NADP+ redox, Pyridoxine (B6) for transamination, Biotin (B7) for carboxylations, Folate (B9) for 1-carbon transfer, and Cobalamin (B12) for methionine and methylmalonyl-CoA conversion.
  • Fat-soluble vitamins function in specialized signaling and anti-oxidative defense: Vitamin A for vision/epithelial maintenance, D for calcium homeostasis, E for membrane lipid antioxidant protection, and K for gamma-glutamyl carboxylation of clotting factors II, VII, IX, X, C, and S.
Last updated: July 2026

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors

Enzymes are biological catalysts that increase reaction rates by lowering the activation energy ($E_a$) required to reach the transition state, without altering the equilibrium constant ($K_{eq}$) or the overall free energy change ($ \Delta G$) of the reaction. Understanding quantitative enzyme kinetics, allosteric modulation, and organic vitamin cofactors is essential for mastering biochemical physiology and clinical pathology on the NPLEX Part I examination.


Quantitative Enzyme Kinetics

The Michaelis-Menten Model

The standard single-substrate enzymatic reaction is represented by:

E+Sk1k1ESkcatE+PE + S \underset{k_{-1}}{\overset{k_1}{\rightleftharpoons}} ES \xrightarrow{k_{cat}} E + P

Where $E$ is free enzyme, $S$ is substrate, $ES$ is the enzyme-substrate complex, and $P$ is product. Under the steady-state assumption—where the concentration of $[ES]$ remains constant because its rate of formation equals its rate of breakdown—the Michaelis-Menten equation expresses initial velocity ($v$) as a function of substrate concentration $[S]$:

v=Vmax[S]Km+[S]v = \frac{V_{max} [S]}{K_m + [S]}

Key parameters include:

  • $V_{max}$ (Maximum Velocity): The theoretical upper limit of reaction rate achieved when the enzyme is fully saturated with substrate ($[E]{total} = [ES]$). $V{max} = k_{cat} [E]_{total}$.
  • $K_m$ (Michaelis Constant): The substrate concentration at which initial velocity equals half of maximum velocity ($v = \frac{1}{2} V_{max}$). Formally, $K_m = \frac{k_{-1} + k_{cat}}{k_1}$. An inverse indicator of enzyme-substrate affinity: a low $K_m$ reflects high affinity, requiring low $[S]$ to achieve half-saturation, whereas a high $K_m$ reflects low affinity.
  • $k_{cat}$ (Turnover Number): The number of substrate molecules converted to product per enzyme active site per second when saturated.
  • Catalytic Efficiency ($k_{cat} / K_m$): Evaluates overall enzyme specificity and performance under physiological substrate concentrations.

Lineweaver-Burk Double Reciprocal Plot

Taking the reciprocal of the Michaelis-Menten equation yields the linear Lineweaver-Burk equation:

1v=(KmVmax)1[S]+1Vmax\frac{1}{v} = \left( \frac{K_m}{V_{max}} \right) \frac{1}{[S]} + \frac{1}{V_{max}}

Plotting $\frac{1}{v}$ (y-axis) against $\frac{1}{[S]}$ (x-axis) creates a straight line where:

  • Y-intercept $= \frac{1}{V_{max}}$
  • X-intercept $= -\frac{1}{K_m}$
  • Slope $= \frac{K_m}{V_{max}}$

Reversible Enzyme Inhibition

Reversible inhibitors diminish enzyme activity through non-covalent interactions and are categorized according to their binding sites and effects on $V_{max}$ and $K_m$.

Inhibition TypeBinding SiteEffect on $K_m$Effect on $V_{max}$Lineweaver-Burk Plot SignatureClinical / Reversibility Notes
CompetitiveActive site (competes directly with $S$)Increases ($K_{m,app} > K_m$)UnchangedLines intersect precisely at the Y-axis ($1/V_{max}$)Overcome by increasing $[S]$. Example: Statins inhibiting HMG-CoA reductase.
Non-competitiveAllosteric site (binds $E$ and $ES$ with equal affinity)UnchangedDecreases ($V_{max,app} < V_{max}$)Lines intersect at the X-axis ($-1/K_m$)Cannot be overcome by increasing $[S]$. Example: Lead inhibiting ferrochelatase.
Uncompetitive$ES$ complex only (does not bind free $E$)Decreases ($K_{m,app} < K_m$)Decreases ($V_{max,app} < V_{max}$)Parallel lines (slope $K_m/V_{max}$ remains constant)Ratio $K_m/V_{max}$ unchanged. Example: Lithium inhibiting inositol monophosphatase.

Allosteric Regulation & Sigmoidal Kinetics

Allosteric enzymes do not follow hyperbolic Michaelis-Menten kinetics; instead, they exhibit sigmoidal (S-shaped) velocity curves due to cooperativity among multiple subunit active sites. Binding of substrate or regulatory effectors shifts the equilibrium between two conformational states:

  • T-state (Tense state): Low affinity for substrate.
  • R-state (Relaxed state): High affinity for substrate.

Allosteric effectors are classified into:

  1. K-series Effectors: Alter $K_{0.5}$ (the substrate concentration at half $V_{max}$) without changing $V_{max}$. Positive allosteric effectors shift the curve to the left (decreasing $K_{0.5}$ and stabilizing R-state); negative effectors shift the curve to the right (increasing $K_{0.5}$ and stabilizing T-state).
  2. V-series Effectors: Alter $V_{max}$ without significantly changing $K_{0.5}$.

---n

Water-Soluble Vitamin Cofactors (B-Complex & Vitamin C)

Water-soluble vitamins serve as precursors for organic coenzymes mediating redox reactions, group transfers, and carboxylations. Because they are not stored in significant quantities (except Vitamin B12 and Folate in liver), deficiencies manifest rapidly.

Vitamin B1 (Thiamine)

  • Active Coenzyme: Thiamine Pyrophosphate (TPP).
  • Biochemical Reactions: Oxidative decarboxylation of $\alpha$-ketoacids: Pyruvate Dehydrogenase, $\alpha$-Ketoglutarate Dehydrogenase, Branched-Chain $\alpha$-Ketoacid Dehydrogenase, and Transketolase (Pentose Phosphate Pathway).
  • Deficiency Syndromes:
    • Dry Beriberi: Peripheral neuropathy, symmetrical muscle wasting, sensory deficits.
    • Wet Beriberi: High-output heart failure, peripheral edema, dilated cardiomyopathy.
    • Wernicke-Korsakoff Syndrome: Common in chronic alcoholism. Triad of confusion, ataxia, and ophthalmoplegia (Wernicke's encephalopathy); progresses to irreversible memory impairment, confabulation, and psychosis (Korsakoff's psychosis) due to damage to mammillary bodies and medial dorsal thalamus.

Vitamin B2 (Riboflavin)

  • Active Coenzymes: Flavin Mononucleotide (FMN) and Flavin Adenine Dinucleotide (FAD).
  • Biochemical Function: Electron transfers in redox reactions (e.g., Complex I & II of ETC, Succinate Dehydrogenase, Acyl-CoA Dehydrogenase).
  • Deficiency: Cheilosis (fissures at corners of mouth), angular stomatitis, glossitis (magenta-colored tongue), corneal neovascularization, and seborrheic dermatitis.

Vitamin B3 (Niacin / Nicotinic Acid)

  • Active Coenzymes: Nicotinamide Adenine Dinucleotide ($\text{NAD}^+$) and Nicotinamide Adenine Dinucleotide Phosphate ($\text{NADP}^+$). Synthesized endogenously from Tryptophan (requires B2 and B6).
  • Biochemical Function: Dehydrogenase reactions ($\text{NAD}^+$ used in catabolism; $\text{NADP}^+$ used in anabolic synthesis, NADPH for glutathione reduction).
  • Deficiency (Pellagra): Classic triad of The 3 Ds: Dermatitis (photosensitive hyperpigmented rash in broad-collar distribution / Casal necklace), Diarrhea, and Dementia (plus death if untreated). Caused by malnutrition, Hartnup disease (impaired neutral amino acid transport), or Carcinoid syndrome (excessive tryptophan consumption for serotonin synthesis).
  • Toxicity: Niacin flush (prostaglandin-mediated facial cutaneous vasodilation), hyperuricemia, hyperglycemia.

Vitamin B5 (Pantothenic Acid)

  • Active Coenzyme: Coenzyme A (CoA) and Acyl Carrier Protein (ACP).
  • Biochemical Function: Acyl group carrier; essential for citrate synthase, fatty acid synthesis, beta-oxidation, and pyruvate entry into TCA cycle.
  • Deficiency: Rare; burning feet syndrome, abdominal cramps, paresthesias.

Vitamin B6 (Pyridoxine)

  • Active Coenzyme: Pyridoxal Phosphate (PLP).
  • Biochemical Reactions: Transamination (ALT, AST), decarboxylation (glutamate to GABA, histidine to histamine), glycogen phosphorylase, and $\delta$-aminolevulinic acid (ALA) synthase (heme synthesis).
  • Deficiency: Sideroblastic anemia (impaired heme synthesis), peripheral neuropathy, convulsions, irritability. Frequently induced by Isoniazid anti-tuberculosis therapy or oral contraceptives.

Vitamin B7 (Biotin)

  • Active Form: Covalently bound biotin (biocytin).
  • Biochemical Function: Carbon dioxide carrier for Carboxylase enzymes:
    1. Pyruvate Carboxylase (gluconeogenesis: pyruvate $\rightarrow$ oxaloacetate)
    2. Acetyl-CoA Carboxylase (fatty acid synthesis: acetyl-CoA $\rightarrow$ malonyl-CoA)
    3. Propionyl-CoA Carboxylase (odd-chain fatty acid catabolism: propionyl-CoA $\rightarrow$ methylmalonyl-CoA)
  • Deficiency: Dermatitis, alopecia, enteritis. Induced by massive ingestion of raw egg whites containing avidin, a glycoprotein that binds biotin with extremely high affinity.

Vitamin B9 (Folate / Folic Acid)

  • Active Form: Tetrahydrofolate (THF).
  • Biochemical Function: 1-Carbon group transfer (methyl, methylene, formyl); crucial for purine synthesis and thymidylate (dTMP) synthesis.
  • Deficiency: Megaloblastic anemia (hypersegmented neutrophils, macrocytic RBCs) with normal methylmalonic acid levels (distinguishing it from B12 deficiency); Neural tube defects (anencephaly, spina bifida) if deficient during early pregnancy. No neurological symptoms.

Vitamin B12 (Cobalamin)

  • Active Forms: Methylcobalamin and S-adenosylcobalamin.
  • Biochemical Reactions:
    1. Methionine Synthase: Homocysteine + N5-methyl-THF $\rightarrow$ Methionine + THF (transfers methyl group; deficiency traps folate as N5-methyl-THF, causing secondary folate deficiency).
    2. Methylmalonyl-CoA Mutase: Methylmalonyl-CoA $\rightarrow$ Succinyl-CoA.
  • Deficiency: Megaloblastic anemia AND Subacute Combined Degeneration (SCD) of the spinal cord (demyelination of posterior columns and lateral corticospinal tracts due to accumulation of abnormal fatty acids derived from methylmalonic acid). Elevated serum homocysteine AND elevated methylmalonic acid (MMA). Frequently caused by loss of Intrinsic Factor from parietal cell destruction (Pernicious Anemia) or terminal ileum resection.

Vitamin C (Ascorbic Acid)

  • Biochemical Function: Antioxidant; reduces iron to $\text{Fe}^{2+}$ state to enhance intestinal absorption; required for hydroxylation of proline and lysine residues in collagen synthesis; cofactor for dopamine $\beta$-hydroxylase.
  • Deficiency (Scurvy): Perifollicular hemorrhages, corkscrew hairs, swollen bleeding gums, poor wound healing, hemarthrosis, impaired bone formation.

Fat-Soluble Vitamins (A, D, E, K)

Fat-soluble vitamins depend on pancreatic lipase and bile salts for micellar absorption in the small intestine. Malabsorption syndromes (celiac disease, cystic fibrosis, primary biliary cholangitis) impair their absorption.

Vitamin A (Retinoids / Carotenoids)

  • Forms: Retinol, Retinal, Retinoic Acid, $\beta$-carotene.
  • Function: Constituent of visual pigments (rhodopsin in rods); epithelial cell differentiation and maintenance; antioxidant.
  • Deficiency: Night blindness (nyctalopia), xerophthalmia (dry eyes), Bitot spots (keratin debris on conjunctiva), corneal ulceration/keratomalacia, follicular hyperkeratosis, impaired immunity.
  • Toxicity: Acute (nausea, vomiting, vertigo, blurred vision); Chronic (arthralgias, alopecia, hepatomegaly, pseudotumor cerebri/idiopathic intracranial hypertension); Teratogenic (microcephaly, cardiac defects; strict contraindication in pregnancy).

Vitamin D (Calcitriol)

  • Forms: Ergocalciferol ($D_2$, plants); Cholecalciferol ($D_3$, skin photo-conversion of 7-dehydrocholesterol via UV light); 25-hydroxyvitamin D (calcidiol, liver storage); 1,25-dihydroxyvitamin D (calcitriol, active kidney form via 1-alpha-hydroxylase).
  • Function: Increases intestinal absorption of calcium and phosphate; stimulates bone mineralization at physiological levels.
  • Deficiency: Rickets in children (epiphyseal growth plate expansion, bowlegs/genu varum, rachitic rosary); Osteomalacia in adults (unmineralized osteoid matrix, bone pain, pseudofractures).

Vitamin E (Tocopherols / Tocotrienols)

  • Function: Lipid-soluble antioxidant; protects cell membranes and polyunsaturated fatty acids from free radical peroxidation.
  • Deficiency: Hemolytic anemia, acanthocytosis, posterior column and spinocerebellar tract demyelination (muscle weakness, ataxia, loss of proprioception/vibration). Clinical presentation mimics Vitamin B12 deficiency neurological signs, but without megaloblastic anemia or elevated MMA.

Vitamin K (Phylloquinone / Menaquinone)

  • Function: Essential cofactor for $\gamma$-glutamyl carboxylase, which catalyzes post-translational $\gamma$-carboxylation of glutamic acid residues on clotting Factors II, VII, IX, X, Protein C, and Protein S. Enables calcium-binding capability.
  • Mechanism & Target: Epoxide reductase converts inactive vitamin K epoxide back to active reduced vitamin K. Warfarin directly inhibits vitamin K epoxide reductase (VKORC1).
  • Deficiency: Bleeding diathesis, prolonged Prothrombin Time (PT) and International Normalized Ratio (INR), prolonged Activated Partial Thromboplastin Time (aPTT). Neonates are at high risk (hemorrhagic disease of the newborn) due to sterile gut flora and poor placental transfer, requiring routine intramuscular Vitamin K prophylaxis at birth.
Test Your Knowledge

An enzyme-catalyzed reaction is evaluated in the presence of a novel therapeutic compound. Kinetic experiments demonstrate that the inhibitor binds exclusively to the free enzyme at the active site. Which shift on a Lineweaver-Burk double reciprocal plot correctly characterizes this mode of inhibition?

A
B
C
D
Test Your Knowledge

A 54-year-old chronic alcohol intake patient presents to the emergency department with confusion, horizontal nystagmus, and an ataxic gait. Erythrocyte transketolase activity is tested before and after addition of a specific cofactor. Addition of which vitamin derivative will restore normal transketolase activity in this patient?

A
B
C
D
Test Your Knowledge

A 42-year-old patient with Crohn disease affecting the terminal ileum undergoes surgical resection. Two years later, the patient presents with fatigue, paresthesias in the lower extremities, and impaired vibration sense. Laboratory evaluation shows macrocytic anemia. Which biochemical finding is expected in this patient?

A
B
C
D